ABVC BIOPHARMA INC
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 13, 2024.
| ABVC BioPharma, Inc. | |
| By: | /s/ Uttam Patil |
| Uttam Patil | |
| Chief Executive Officer (Principal Executive Officer) | |
| By: | /s/ Leeds Chow |
| Leeds Chow | |
| Chief Financial Officer (Principal Financial Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Uttam Patil | Chief Executive Officer (Principal Executive Officer) | March 13, 2024 |
| Uttam Patil | ||
| /s/ Leeds Chow | Chief Financial Officer (Principal Financial Officer) | March 13, 2024 |
| Leeds Chow | ||
| /s/ Eugene Jiang | Chairman of the Board of Directors | March 13, 2024 |
| Eugene Jiang | ||
| /s/ Yen-Hsin Chou | Director | March 13, 2024 |
| Yen-Hsin Chou | ||
| /s/ Hsin-Hui Miao | Director | March 13, 2024 |
| Hsin-Hui Miao | ||
| /s/ Tsang-Ming Jiang | Director | March 13, 2024 |
| Tsang-Ming Jiang | ||
| /s/ Shuling Jiang | Director | March 13, 2024 |
| Shuling Jiang | ||
| /s/ Norimi Sakamoto | Director | March 13, 2024 |
| Norimi Sakamoto | ||
| /s/ Tsung-Shann Jiang | Director | March 13, 2024 |
| Tsung-Shann Jiang | ||
| /s/ Chang-Jen Jiang | Director | March 13, 2024 |
| Chang-Jen Jiang | ||
| /s/ Yoshinobu Odaira | Director | March 13, 2024 |
| Yoshinobu Odaira | ||
| /s/ Che-Wei Hsu | Director | March 13, 2024 |
| Che-Wei Hsu | ||
| /s/ Yu-Min (Francis) Chung | Director | March 13, 2024 |
| Yu-Min (Francis) Chung | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.